Fifty years after thalidomide; what role for drug regulators?

Br J Clin Pharmacol. 2012 Nov;74(5):731-3. doi: 10.1111/j.1365-2125.2012.04255.x.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Decision Making
  • Drug Approval*
  • Drug Design
  • Drug and Narcotic Control / methods
  • Drug and Narcotic Control / trends*
  • Humans
  • Teratogens / toxicity*
  • Thalidomide / adverse effects

Substances

  • Teratogens
  • Thalidomide